Best-Performing Leveraged ETFs of October

October's top ETF gainers included the likes of NVTX, AMUU, KORU, LABU and INTW. These ETFs soared as AI, crypto and reform ...

Is Eli Lilly a Millionaire Maker?

Weight loss drugs are set to become a disproportionate share of Lilly's business.

3 Things Investors Need to Know About Recursion Pharmaceuticals

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

Pfizer's $4.9 Billion Gamble: Inside Its Legal War to Reclaim the Obesity Market

After raising its 2025 profit forecast again, Pfizer turns its sights on Novo Nordisk in a billion-dollar obesity drug ...

Ryanair expects new Boeing jets to arrive in 2027, fueling growth to 300m passengers a year

Neil Sorahan, its chief financial officer, indicated that it could borrow to pay for the new jets as the deliveries increase ...

OpenAI strikes $38bn computing deal with Amazon

ChatGPT maker OpenAI has signed a $38 billion (€33 billion) deal with Amazon Web Services, the latest in a string of agreements struck by the loss-making start-up as it races to secure computing power ...

Novo Nordisk says Metsera bid won't raise antitrust issues

Denmark's Novo Nordisk said on Monday it is confident that its proposed takeover of U.S. drugmaker Metsera does not raise any ...
Business Post

Grant Thornton Advisors expands into New Zealand

Grant Thornton’s non-audit platform is growing to include Grant Thornton New Zealand.... Nvidia Corp can add trillions more to its valuation after making history as the first... Eli Lilly said on ...